Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in
Advertisement

Anbio Biotechnology NNNN

Set alert

Price alert · NNNN

All alert types
3.50 USD +0.14 +4.17%

As of Nov 2, 1:33 PM ET

Bid
3.45 × 1
Ask
3.80 × 1
3.42 Day range 3.73
3.09 52-week range 44.73
YTD
-88.36%
1 year
-79.23%
Open
3.42
Prev close
3.36
Mkt cap
153.62M
Vol
50.73K
Avg vol
151.59K
EPS
0.15
P/E
23.33
Div yield
0.00%
More statistics
Low
3.42
High
3.73
Forward P/E
0.00
Beta
0.00
Short ratio
1.79
Inst. own
4.90%
Dividend
0.00
Ex-div date
50-d avg
22.29
200-d avg
25.98
1y target
0.00

6M chart

Chart tools
Interval
1m5m15m30m

Signals (27)
NameDateAgo
RSI: OversoldOct 30, 20263 days ago
MACD: Buy SignalOct 23, 20261 week ago
MACD: Sell SignalOct 8, 20263 weeks ago
RSI: OversoldOct 5, 20264 weeks ago
MACD: Buy SignalSep 21, 20261 month ago
MACD: Sell SignalSep 18, 20261 month ago
RSI: OversoldSep 3, 20262 months ago
MACD: Buy SignalAug 27, 20262 months ago
RSI: OversoldAug 20, 20262 months ago
MACD: Sell SignalAug 19, 20262 months ago
MACD: Buy SignalJul 14, 20263 months ago
MACD: Sell SignalJul 10, 20263 months ago
MACD: Buy SignalJul 9, 20263 months ago
RSI: OversoldJun 29, 20264 months ago
RSI: OversoldJun 24, 20264 months ago
RSI: OversoldJun 16, 20264 months ago
RSI: OversoldJun 8, 20264 months ago
SMA: BearishJun 5, 20265 months ago
SMA: BearishJun 4, 20265 months ago
MACD: Sell SignalJun 3, 20265 months ago
MACD: Buy SignalMay 19, 20265 months ago
SMA: BullishMay 15, 20265 months ago
SMA: BullishMay 15, 20265 months ago
SMA: BearishMay 13, 20265 months ago
SMA: BearishMay 6, 20266 months ago
MACD: Sell SignalMay 6, 20266 months ago
MACD: Buy SignalMay 4, 20266 months ago

Key statistics

Financials
Market cap
412.14M
Enterprise value
400.24M
Trailing P/E
62.60
Forward P/E
0.00
PEG ratio
0.00
Price / sales
47.66
Price / book
13.67
EPS (TTM)
0.15
Beta
0.00
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
74.06%
Revenue (TTM)
8.65M
Revenue growth
73.90%
Free cash flow
-9.61M
Total cash
11.90M
Total debt
0
Return on equity
27.05%
Shares outstanding
43.89M
Short % of float
0.20%
50-day average
22.29
200-day average
25.98

Analyst view

Consensus: none

Price target (mean) 0.00

Next earnings

Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
NNNN Revenue — annual 8.65M
2022-FY 20222023-FY 20232024-FY 20242025-FY 2025
NNNN Net income — annual 6.40M
2022-FY 20222023-FY 20232024-FY 20242025-FY 2025
NNNN EPS — annual 0.147
2022-FY 20222023-FY 20232024-FY 20242025-FY 2025

About Anbio Biotechnology

Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, SHA dry chemistry, chemiluminescence immunoassay, and real-time polymerase chain reaction solutions; and SARS-CoV-2 and SARS-CoV-2/Flu A/Flu B antigen rapid test kits. It serves over-the-counter, point-of-care testing, and laboratory markets. Anbio Biotechnology was incorporated in 2021 and is based in Frankfurt am Main, Germany.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
Germany
Website
anbiobiotechnology.com

News

All news

Your note

Sign in to keep a note on NNNN — it syncs with the Stock Master app.

Institution ownership

NNNN institution ownership
Holder% heldSharesValueReported
Geode Capital Management, LLC0.06%25,763241.91KMar 30, 2026
BNP Paribas Financial Markets0.02%10,40097.66KMar 30, 2026
Morgan Stanley0.02%7,33868.90KMar 30, 2026
UBS Group AG0.01%6,33959.52KMar 30, 2026
Blue Trust, Inc.0.00%546Mar 30, 2026
Wells Fargo & Company0.00%100939Mar 30, 2026

Fund ownership

NNNN fund ownership
Holder% heldSharesValueReported
Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund0.06%26,736251.05KMay 30, 2026
Advertisement